Shares of the contract development and manufacturing organization Avid Bioservices (NASDAQ: CDMO) were up by a healthy 34% on heavy volume as of 11 a.m. ET Tuesday. After this double-digit move higher, the bio-manufacturing company's stock is now trading at 6.5 times 2024 estimated sales.
Avid Bioservices (NASDAQ:CDMO) has had a rough month with its share price down 16%. However, a closer look at its sound...
Q3 2023 Avid Bioservices Inc Earnings Call